This country profile provides an overview of Mauritania’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
N/A
Bilharzia
56%
River blindness
N/A
213k
people received treatment in Mauritania in 2019
614k
people did not receive treatment in Mauritania in 2019
Elephantiasis
Mauritania does not require mass treatment for elephantiasis.
Blinding trachoma
Mauritania is conducting post-preventive chemotherapy surveillance.
Intestinal worms
Mauritania does not require mass treatment for intestinal worms.
Bilharzia
Treatment coverage decreased from 77% in 2018 to 56% in 2019.
School-aged children needing treatment
383k
School-aged children receiving treatment
213k
River blindness
Mauritania does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mauritania.